4 Translational Projects Selected in the First NeuroCure / SPARK-BIH Call

Several teams from the field of Neuroscience applied to the first NeuroCure / SPARK-BIH Call for translational proposals. The NeuroCure board approved the funding of 4 teams that have entered the SPARK-BIH mentoring program in Fall 2020.

NeuroCure is a cluster of excellence in the field of Neuroscience in Berlin, Germany. The primary aim of this interdisciplinary network is to explore and understand the mechanisms of diseases in the central neural system in order to find potential new therapies for neurological and psychiatric disorders. This year, NeuroCure and SPARK-BIH joined forces to identify the best translational projects from the Neuroscience community to be part in the SPARK-BIH program.

Selected teams were invited to present their projects in short pitch presentations in front of an expert jury on the September 17th at the BIH headquarters. The projects are all associated to the field of Neuroscience but are addressing a broad range of clinical problems: from development of new pharmacological therapies for rare diseases, over medical devices for non-invasive modulation of deep-brain activity to screening for biomarkers for neurological side effects.

Based on the ranking by the reviewers at the evaluation event, the NeuroCure board made a final funding decision. 4 teams (2 Pharma projects, 1 MedTech project and 1 Diagnostic project) will receive funding by NeuroCure as well as mentorship from the SPARK-BIH program. The photo was taken during the evaluation event by Stephan Niespodziany.

SPARK-BIH is a member of the SPARK Global network